[Home ] [Archive]    
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Home::
IJRR Information::
About the Journal
Editorial Board
Keywords
For Authors::
Aims and Scope
Call for Papers
Submission Instructions
For Reviewers::
Referee page
Subscription::
Subscription Form
News & Events::
Journal News
Web Mail::
::
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
ISSN
Hard Copy 2322-3243
Online 2345-4229
..
Online Submission
Now you can send your articles to IJRR office using the article submission system.
..

AWT IMAGE

AWT IMAGE
:: Volume 22, Issue 2 (4-2024) ::
Int J Radiat Res 2024, 22(2): 309-313 Back to browse issues page
Inappropriate probe positioning during radioactive iodine uptake measurements cause inaccurate 131I quantification in patients with Graves' disease
J. Zeng , T. Zhang , Y. Yang , J. Wang , X. Han , Q. Guo , Y. Fang
Department of Endocrinology, Fifth Medical Center of Chinese PLA General Hospital, Beijing 100071, China , fangyi5zhongxin@163.com
Abstract:   (295 Views)
Background: To evaluate the effects of probe positioning on radioactive iodine uptake (RAIU) measurements and 131I quantification in Graves disease (GD) patients. Materials and Methods: We performed a cross-sectional study in GD patients between May 9 and June 27, 2013. 24 hr-RAIU was measured. Measurement A was the reference measurement and was obtained with the probe parallel to the bottom of the thyroid cartilage. Measurements B, C, D, and E were obtained by moving the probe 2.5 cm to the left, 5 cm to the left, 2.5 cm vertically upward, and 5 cm vertically upward, respectively. The 131I doses were calculated. Non-reference measurements were compared with measurement A using the paired t-test or Wilcoxon signed-rank test. Results: A total of 63 GD patients (17 men, 40.3±13.6 years old) were enrolled. Among them, 57 patients had 24 hr-RAIU measurement and 37 patients chose the 131I treatment. Significant changes were observed in 24 hr-RAIU and 131I dose between measurement A (24 hr-RAIU 60.40±12.67% and median 131I dose 8.17 mCi) and measurement E (24 hr-RAIU 48.67±11.74% and median 131I dose 9.50 mCi) (P<0.05). In one patient, the 24 hr-RAIU was 20.3% lower in measurement E compared with that in measurement A, resulting in a 30 mCi increase in the calculated 131I dose. Conclusions: The vertically upward movement by a distance of a radius of the collimator could affect the 24 hr-RAIU measurement and thus cause inaccurate calculation of the 131I dose.
Keywords: Thyroid function tests, iodine radioisotopes, Graves’ disease, data accuracy.
Full-Text [PDF 590 kb]   (63 Downloads)    
Type of Study: Original Research | Subject: Radiation Biology
References
1. Husseni MA (2016) The Incidence of Hypothyroidism Following the Radioactive Iodine Treatment of Graves' Disease and the Predictive Factors Influencing its Development. World J Nucl Med, 15(1): 30-37. [DOI:10.4103/1450-1147.167582]
2. Kalinyak JE and McDougall IR (2003) How should the dose of iodine-131 be determined in the treatment of Graves' hyperthyroidism? J Clin Endocrinol Metab, 88(3): 975-977. [DOI:10.1210/jc.2002-021801]
3. Pelletier-Galarneau M, Martineau P, Klein R, et al. (2018) Reproducibility of radioactive iodine uptake (RAIU) measurements. J Appl Clin Med Phys, 19(1): 239-242. [DOI:10.1002/acm2.12217]
4. Li C, Song J, Ba J, Lin Y (2013) The influence of position deviation on RAIU and, the corresponding therapeutic dose calculations in patients with Graves hyperthyroidism. China Medical Abstracts: internal Medicine, 2: 65-66.
5. Nygaard B (2010) Hyperthyroidism (primary). BMJ Clin Evid, 2010: 0611. [DOI:10.1055/s-0029-1219738]
6. Giovanella L, Avram AM, Iakovou I, et al. (2019) EANM practice guideline/SNMMI procedure standard for RAIU and thyroid scintigraphy. Eur J Nucl Med Mol Imaging, 46(12): 2514-2525. [DOI:10.1007/s00259-019-04472-8]
7. Balon HR, Silberstein EB, Meier DA, et al. (2006) Society of Nuclear Medicine Procedure Guideline for Thyroid Uptake Measurement.
8. Şahmaran T and Gültekin SS (2021) Least significant changes and reproducibility of 131i uptake test. Health Phys, 120(3): 316-320. [DOI:10.1097/HP.0000000000001325]
9. Hayes AA, Akre CM, Gorman CA (1990) Iodine-131 treatment of Graves' disease using modified early iodine-131 uptake measurements in therapy dose calculations. J Nucl Med, 31(4): 519-522.
10. de Bruin TW, Croon CD, de Klerk JM, van Isselt JW (1994) Standardized radioiodine therapy in Graves' disease: the persistent effect of thyroid weight and radioiodine uptake on outcome. J Intern Med, 236(5): 507-513. [DOI:10.1111/j.1365-2796.1994.tb00837.x]
11. Törring O, Tallstedt L, Wallin G, et al. (1996) Graves' hyperthyroidism: treatment with antithyroid drugs, surgery, or radioiodine--a prospective, randomized study. Thyroid Study Group. J Clin Endocrinol Metab, 81(8): 2986-2993. [DOI:10.1210/jcem.81.8.8768863]
12. Sridama V, McCormick M, Kaplan EL, et al. (1984) Long-term follow-up study of compensated low-dose 131I therapy for Graves' disease. N Engl J Med, 311(7): 426-432. [DOI:10.1056/NEJM198408163110702]
13. Willemsen UF, Knesewitsch P, Kreisig T, et al. (1993) Functional results of radioiodine therapy with a 300-Gy absorbed dose in Graves' disease. Eur J Nucl Med, 20(11): 1051-1055. [DOI:10.1007/BF00173482]
14. Shahid MA, Ashraf MA, Sharma S (2023) Physiology, Thyroid Hormone. StatPearls Publishing, Treasure Island (FL).
15. Ariamanesh S, Ayati N, Mazloum Khorasani Z, et al. (2020) Effect of different 131I dose strategies for treatment of hyperthyroidism on Graves' ophthalmopathy. Clin Nucl Med, 45(7): 514-518. [DOI:10.1097/RLU.0000000000003086]
16. Xing YZ, Zhang K, Jin G (2020) Predictive factors for the outcomes of Graves' disease patients with radioactive iodine (131I) treatment. Biosci Rep, 40(1): BSR20191609. [DOI:10.1042/BSR20191609]
17. Brudecki K, Kluczewska-Gałka A, Zagrodzki P, et al. (2020) (131)I thyroid activity and committed dose assessment among family members of patients treated with radioactive iodine. Radiat Environ Biophys, 59(3): 559-564. [DOI:10.1007/s00411-020-00860-z]
18. IAEA (1987) Domestic- Industry standard- Nuclear industry CN-EJ. Technical requirements for the detector of probe of RAIU. EJ/T 298-1987.
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA

XML     Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Zeng J, Zhang T, Yang Y, Wang J, Han X, Guo Q et al . Inappropriate probe positioning during radioactive iodine uptake measurements cause inaccurate 131I quantification in patients with Graves' disease. Int J Radiat Res 2024; 22 (2) :309-313
URL: http://ijrr.com/article-1-5414-en.html
Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 22, Issue 2 (4-2024) Back to browse issues page
International Journal of Radiation Research
Persian site map - English site map - Created in 0.05 seconds with 50 queries by YEKTAWEB 4657